Skip to content
  1. Home
  2. Fitness & muscle
  3. Somatropin

Fitness & muscle

Somatropin

FDA-approved recombinant growth hormone for deficiency, widely used off-label for performance and body composition.

FDA-approved (GHD treatment) Fitness & muscle Anti-aging Recovery & healing

Reviewed 2026-09-12
Full name
Recombinant human growth hormone, 191-amino acid
Also known as
rHGH, rhGH, synthetic human growth hormone, HGH 191AA
Regulatory status
FDA-approved (GHD treatment) | Off-label use widespread

Origin

Recombinant human growth hormone produced via genetic engineering starting in the 1980s, replacing cadaver-derived pituitary extracts. Now available in daily and long-acting pegylated/fusion formulations.

Mechanism

Binds growth hormone receptor (GHR) on target tissues, promoting IGF-1 production in the liver (endocrine) and peripheral tissues (autocrine/paracrine). Stimulates lipolysis, amino acid uptake, protein synthesis in muscle, and bone mineral density.

Research summary

Evidence

Long-acting GH formulations show non-inferiority to daily GH in height velocity and similar safety. Approved for childhood and adult GHD. Off-label performance use is common but carries risks including hyperglycemia, insulin resistance, and carpal tunnel syndrome; long-term safety data in off-label populations is limited.

Evidence tier: FDA-approved (GHD treatment) — see the methodology note for how this is assessed.

Citations

Reported benefits

  • increased lean muscle mass
  • improved body composition
  • enhanced recovery
  • increased bone mineral density

Dosing protocols reported in the literature & community

These are protocols reported by compounding pharmacies, published trials, or self-experimentation communities — not a prescription. Start low, especially for anything new.

Reported dosing protocols
RouteReported protocol
Subcutaneous injectionFDA: 0.04-0.1 mg/kg/day (adult GHD). Off-label athletic use: typically 2-6 IU daily or 4-8 IU every other day.

Side effects

  • hyperglycemia
  • insulin resistance
  • carpal tunnel syndrome
  • gynecomastia
  • fluid retention
  • joint pain

Safety notes

Safety: FDA-approved only for documented GHD. Off-label supraphysiological use carries undefined long-term risk. Contraindicated in active cancer. Requires monitoring of glucose, IGF-1, bone density.
Community & reddit notes (anecdotal — not clinical evidence)

Widely sourced from underground labs and diverted pharmaceutical supply. Common protocols 2-10 IU daily, often stacked with secretagogues. Users report muscle/recovery gains alongside water retention and joint pain.

Mixing compatibility

Pulled from a community-charted mixing-compatibility reference (anecdotal, clinic-use, and community-reported signals) — not a safety guarantee. Verify independently before combining anything.

Anecdotally combined (outside clinic protocols)

Reported as a combination to avoid